A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

NCT03314935 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer (BTC)
Colorectal Cancer (CRC)
Endometrial Cancer
Gastroesophageal Cancer (GC)
Ovarian Cancer
Solid Tumors

Interventions

DRUG: INCB001158
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: 5-Fluorouracil
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Paclitaxel

Sponsor

Incyte Corporation